for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Applied DNA Sciences Inc

APDN.OQ

Latest Trade

0.21USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

0.20

 - 

1.55

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.21
Open
--
Volume
--
3M AVG Volume
11.11
Today's High
--
Today's Low
--
52 Week High
1.55
52 Week Low
0.20
Shares Out (MIL)
48.02
Market Cap (MIL)
9.80
Forward P/E
-1.07
Dividend (Yield %)
--

Next Event

Applied DNA Sciences Inc Annual Shareholders Meeting

Latest Developments

More

Applied DNA Sciences Announces Q3 Loss Per Share $0.04

Applied DNA Signs Master Services Agreement With Schreiner Group To Deliver Signature DNA Labels To Protect Pharmaceutical Supply Chains

Applied DNA And Theracann International Sign Term Sheet To Amend Licensing And Cooperation Agreement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Applied DNA Sciences Inc

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company's platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.

Industry

Chemical Manufacturing

Contact Info

50 Health Sciences Dr

+1.631.2408800

http://www.adnas.com/

Executive Leadership

James A. Hayward

Chairman of the Board, President, Chief Executive Officer

Beth M. Jantzen

Chief Financial Officer

Judith Murrah

Chief Information Officer

Ming-Hwa Liang

Secretary, Strategic Technology Development Officer

Robert B. Catell

Director

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2016

-0.510

2017

-0.490

2018

-0.400

2019(E)

-0.190
Price To Earnings (TTM)
--
Price To Sales (TTM)
1.99
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-483.03
Return on Equity (TTM)
-226.71

Latest News

Latest News

BRIEF-Applied DNA Sciences Signs A 5-Year Pact With Montblanc-Simplo GMBH

* APPLIED DNA SIGNS 5-YEAR AGREEMENT WITH ICONIC WRITING INSTRUMENT SPECIALIST MONTBLANC-SIMPLO GMBH TO PROVIDE SIGNATURE® DNA WITH BEACON® TO PRESTIGE MONTBLANC CLIENTS

BRIEF-Applied DNA Reports Q2 Loss Per Share Of $0.07

* APPLIED DNA REPORTS FISCAL SECOND QUARTER 2018 FINANCIAL RESULTS

BRIEF-Applied DNA Signs Agreements With Colorcon For Molecular Tagging In Pharmaceutical, Nutraceutical Markets

* APPLIED DNA SIGNS DEFINITIVE AGREEMENTS WITH COLORCON FOR MOLECULAR TAGGING IN THE PHARMACEUTICAL AND NUTRACEUTICAL MARKETS

BRIEF-Applied DNA Reports Q1 Loss Per Share $0.12

* APPLIED DNA REPORTS FISCAL FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-DNA Q4 EBITDA EUR 65.7​ mln

* REG-DNA PLC'S FINANCIAL STATEMENTS BULLETIN 2017: DNA'S NET SALES AND OPERATING RESULT REACH RECORD LEVELS IN 2017

BRIEF-Applied DNA Sciences Establishes New Central DNA Testing Laboratory In India

* APPLIED DNA SCIENCES INC SAYS HAS ESTABLISHED A CENTRAL DNA TESTING LABORATORY IN AHMEDABAD, INDIA, PROVIDING FULL FORENSIC AUTHENTICATION SERVICES Source text for Eikon: Further company coverage:

BRIEF-Applied DNA Sciences Q4 Revenue $1.1 Million

* APPLIED DNA SCIENCES REPORTS YEAR END AND FISCAL FOURTH QUARTER RESULTS

BRIEF-Applied DNA And Colorcon To Collaborate To Commercialize Product Authentication Technology

* APPLIED DNA AND COLORCON ANNOUNCE COLLABORATION TO COMMERCIALIZE PRODUCT AUTHENTICATION TECHNOLOGY FOR PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY

BRIEF-Applied DNA Q4 Loss Per Share $0.10

* APPLIED DNA ANNOUNCES SELECTED PRELIMINARY UNAUDITED FISCAL FOURTH QUARTER AND YEAR END RESULTS

BRIEF-APPLIED DNA SECURES 1-YEAR CONTRACT EXTENSION WITH DEFENSE LOGISTICS AGENCY

* APPLIED DNA SCIENCES INC - DEFENSE LOGISTICS AGENCY (DLA) HAS AWARDED CO A ONE-YEAR EXTENSION OF ITS CURRENT CONTRACT THROUGH OCTOBER 13, 2018 Source text for Eikon: Further company coverage:

BRIEF-Applied DNA signs Cooperative Research And Development Agreement with U.S. Army

* Applied DNA signs Cooperative Research And Development Agreement with U.S. Army to study commercialization of rapid in-field DNA detection technology

BRIEF-TransUnion acquires Datalink Services Inc

* TransUnion enhances insurance capabilities with acquisition of Datalink Services, Inc.

BRIEF-Applied DNA Q3 loss per share $0.10

* Applied DNA reports fiscal third quarter 2017 financial results

BRIEF-Applied DNA Sciences to begin production testing with a U.S.-based bearings manufacturer

* Applied DNA Sciences Inc - commencing production-scale DNA marking of bearings with manufacture , at a domestic manufacturing facility Source text for Eikon: Further company coverage:

BRIEF-Applied DNA wins 2-year, $1.5 mln competitive-bid development contract from the Office of the Secretary of Defense

* Applied DNA wins two-year, $1.5 million competitive development contract from the Office of the Secretary of Defense

BRIEF-Applied DNA Sciences files for mixed shelf of up to $25 mln

* Applied DNA Sciences Inc files for mixed shelf of up to $25 million - SEC filing Source text for Eikon: (http://bit.ly/2qda5ec) Further company coverage:

BRIEF-Applied DNA Sciences appoints Elizabeth Schmalz Ferguson to board

* Applied DNA Sciences appoints cosmetic industry veteran Elizabeth M. Schmalz Ferguson to board of directors

BRIEF-Applied DNA Sciences reports Q2 loss per share $0.13

* Applied DNA Sciences reports fiscal second quarter 2017 financial results

BRIEF-Applied DNA Sciences signs 5-year supply agreement for bulk DNA manufacturing

* Applied DNA Sciences signs 5-year supply agreement for bulk DNA manufacturing

BRIEF-DNA chosen by EPV Energia to supply net security services

* Has been chosen by EPV Energia to supply net security services

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up